Trial Profile
Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha 'Registered' In Subjects With Hemophilia A
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Moroctocog alfa (Primary)
- Indications Haemophilia A
- Focus Adverse reactions
- Sponsors Pfizer
- 05 May 2015 New trial record